Mr. John McMullen reports

LGC CAPITAL'S LITTLE GREEN PHARMA COMPLETES THEIR FIRST AUSTRALIAN MEDICAL CANNABIS HARVEST

LGC Capital Ltd.'s Australian medical cannabis limited partnership, Little Green Pharma, has completed its first Australian harvest this week.

LGC recently increased its strategic interest in Little Green Pharma to 14.99 per cent.

Postmanufacturing and subject to the strict Therapeutic Goods Order No. 93 mandatory testing, Little Green Pharma expects to have the first Australian-grown medicinal cannabis products available for sale both domestically and internationally.

John McMullen, chief executive officer of LGC, commented: "This is a great milestone for Little Green Pharma and their team. This is one of the first crops grown and harvested in Australia and we look forward to their unique product offering."

Fleta Solomon, Little Green Pharma's managing director, commented, "This is a great step toward the company's vision of being one of the first companies in Australia to produce a high-quality, locally grown medicine for patients both in Australia and around the world."

About LGC Capital Ltd.

LGC Capital is a Canadian-incorporated public company listed on the TSX Venture Exchange. LGC's objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services with an emphasis on significant investments in global medical cannabis sector.

We seek Safe Harbor.